These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15285849)

  • 1. Inhibition of human cytochromes P450 by components of Ginkgo biloba.
    von Moltke LL; Weemhoff JL; Bedir E; Khan IA; Harmatz JS; Goldman P; Greenblatt DJ
    J Pharm Pharmacol; 2004 Aug; 56(8):1039-44. PubMed ID: 15285849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
    Chang TK; Chen J; Yeung EY
    Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols.
    Lau AJ; Chang TK
    Drug Metab Dispos; 2009 Sep; 37(9):1931-7. PubMed ID: 19487249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Ginkgo biloba extract on rat hepatic microsomal CYP1A activity: role of ginkgolides, bilobalide, and flavonols.
    Kuo If; Chen J; Chang TK
    Can J Physiol Pharmacol; 2004 Jan; 82(1):57-64. PubMed ID: 15052306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals.
    van Beek TA; Montoro P
    J Chromatogr A; 2009 Mar; 1216(11):2002-32. PubMed ID: 19195661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract.
    Gaudineau C; Beckerman R; Welbourn S; Auclair K
    Biochem Biophys Res Commun; 2004 Jun; 318(4):1072-8. PubMed ID: 15147983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of cytochrome P450s by terpene trilactones and flavonoids of the Ginkgo biloba extract EGb 761 in rats.
    Deng Y; Bi HC; Zhao LZ; He F; Liu YQ; Yu JJ; Ou ZM; Ding L; Chen X; Huang ZY; Huang M; Zhou SF
    Xenobiotica; 2008 May; 38(5):465-81. PubMed ID: 18421621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Ginkgo biloba extract on oxidative metabolism of valproic acid in hepatic microsomes from donors with the CYP2C9*1/*1 genotype.
    Numa AM; Abbott FS; Chang TK
    Can J Physiol Pharmacol; 2007 Sep; 85(9):848-55. PubMed ID: 18066130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9.
    Yale SH; Glurich I
    J Altern Complement Med; 2005 Jun; 11(3):433-9. PubMed ID: 15992226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VERIFICATION OF AUTHENTICITY OF
    Budeč M; Bošnir J; Racz A; Lasić D; Brkić D; Mosović Ćuić A; Kuharić Ž; Jurak G; Barušić L
    Acta Clin Croat; 2019 Dec; 58(4):672-692. PubMed ID: 32595253
    [No Abstract]   [Full Text] [Related]  

  • 11. Bilobalide in Ginkgo biloba extract is a major substance inducing hepatic CYPs.
    Umegaki K; Taki Y; Endoh K; Taku K; Tanabe H; Shinozuka K; Sugiyama T
    J Pharm Pharmacol; 2007 Jun; 59(6):871-7. PubMed ID: 17637180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct analysis of 18 flavonol glycosides, aglycones and terpene trilactones in Ginkgo biloba tablets by matrix solid phase dispersion coupled with ultra-high performance liquid chromatography tandem triple quadrupole mass spectrometry.
    Liu XG; Yang H; Cheng XL; Liu L; Qin Y; Wang Q; Qi LW; Li P
    J Pharm Biomed Anal; 2014 Aug; 97():123-8. PubMed ID: 24876067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents.
    Etheridge AS; Black SR; Patel PR; So J; Mathews JM
    Planta Med; 2007 Jul; 73(8):731-41. PubMed ID: 17611934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic lipase inhibition activity of trilactone terpenes of Ginkgo biloba.
    Bustanji Y; Al-Masri IM; Mohammad M; Hudaib M; Tawaha K; Tarazi H; Alkhatib HS
    J Enzyme Inhib Med Chem; 2011 Aug; 26(4):453-9. PubMed ID: 21028941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids.
    Mohamed MF; Frye RF
    Drug Metab Dispos; 2010 Feb; 38(2):270-5. PubMed ID: 19889883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method for extraction and quantification of Ginkgo terpene trilactones.
    Ding C; Chen E; Zhou W; Lindsay RC
    Anal Chem; 2004 Aug; 76(15):4332-6. PubMed ID: 15283569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory effects of herbal components on CYP2C9 and CYP3A4 catalytic activities in human liver microsomes.
    He N; Edeki T
    Am J Ther; 2004; 11(3):206-12. PubMed ID: 15133536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of pharmacokinetic profile of different parts from Ginkgo biloba extract in rats.
    Guan H; Qian D; Ren H; Zhang W; Nie H; Shang E; Duan J
    J Ethnopharmacol; 2014 Aug; 155(1):758-68. PubMed ID: 24953034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of reverse-flow micellar electrokinetic chromatography for the simultaneous determination of flavonols and terpene trilactones in Ginkgo biloba dosage forms.
    Dubber MJ; Kanfer I
    J Chromatogr A; 2006 Jul; 1122(1-2):266-74. PubMed ID: 16720026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity.
    Zou L; Harkey MR; Henderson GL
    Life Sci; 2002 Aug; 71(13):1579-89. PubMed ID: 12127912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.